They claim that the HIV vaccine is closer to reality

July 8, 2018 | | | 52 times read

A new experimental vaccine protected the monkeys from infection. Whatever the case may be, an Argentine specialist has asked "not to encourage false expectations".

The researchers announced that they had tested an experimental vaccine against the human immunodeficiency virus (HIV) that protected monkeys from infection. An important step "toward creating a vaccine, said study director, virologist Dan Barouch, in a statement in The Lancet magazine.

However, he cautioned there is no guarantee that the next tests will be positive. "We must be cautious," he told the AFP news agency. The results of the wider tests are expected in 2021 or 2022.

In the same sense, the famous Argentine expert of infectious diseases Pedro Cahn was expressed in dialogue with Clarín. "It is good news. "He showed that he gave protection to the monkeys but he still can not be extended to humans.We are on the right track but he is absolutely uncertain in the sense.Do not encourage false expectations." , said the creator of the Huésped Foundation

.This is the "fifth concept vaccine" against HIV tested in 35 years, according to Barouch.

The study was conducted at 393 healthy, seronegative adults, between 18 and 50 years of age in East Africa, South Africa, Thailand and the US Some of them received a placebo

showed the safety of the combination vaccine, which included different types of HIV virus, with only five participants with adverse effects such as diarrhea or dizziness

.The third of the 72 rhesus macaques that the researchers tried after the Inoculation of the virus

"This is surely not the definitive film, but it can be a phenomenal breakthrough, "said French Jean-Daniel Lelièvre of the Vaccine Research Institute. . "At best", these surveys will produce a vaccine that can be administered in "about 10 years."

According to the World Health Organization (WHO), some 37 million people are living with HIV and 1.8 million are contracting it each year. The disease has killed about 35 million of the 80 million that it has infected since its first diagnosis in the 1980s.

Despite advances in medicine in the prevention and treatment of the disease, (PrEP, antiretrovirals , triterapias), the researchers insist on the measures to be taken to avoid the infection: protection during bad, use of new syringes and sterilization of medical equipment, among others.